What analyst predict for NuVasive Inc NASDAQ:NUVA

2
447

What analyst predict for NuVasive Inc NASDAQ:NUVA

NuVasive Inc NASDAQ:NUVA

NuVasive, Inc. is expected to report earnings on 02/26/2018 after market close. The report will be for the fiscal Quarter ending Dec 2017. According to Zacks Investment Research, based on 8 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.56. The reported EPS for the same quarter last year was $0.53.

CEO: Gregory T. Lucier (26 May 2015–)
()
()

Quarterly Earnings Surprise History

Fiscal
Quarter End
Date
Reported
Earnings
Per Share
Consensus
EPS* Forecast
%
Surprise
Sep2017 10/24/2017 0.52 0.48 8.33
Jun2017 07/27/2017 0.46 0.44 4.55
Mar2017 04/25/2017 0.38 0.37 2.7
Dec2016 02/09/2017 0.53 0.5 6

Overview

We develop minimally disruptive, procedurally-integrated solutions for spine and beyond.

Our mission is to improve the lives of patients who suffer from
debilitating back, neck, or leg pain by creating cutting-edge
products and procedures that revolutionize spine surgery.

Chart

NUVA
Name
Change
% Change
Market Cap
% Change from 52 Week Low
% Change from 52 Week High
Shares Outstanding
Volume
Dividend Rate

2 COMMENTS

  1. […] What analyst predict for NuVasive Inc NASDAQ:NUVA (stockmarketdaily.co) […]

  2. […] What analyst predict for NuVasive Inc NASDAQ:NUVA (stockmarketdaily.co) […]

Comments are closed.